https://doi.org/10.4081/mem.1997.886
Prenatal tests to predict the risk of fetal chromosomal syndrome
Scientific, ethical and deontological aspects
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The prenatal diagnosis of syndromes caused by alterations of genetic information have been part of medical assistence for the last thirty years. Deontological criteria and ethical considerations about respect for the correct requirements and rights of the parents, on the one hand, and the safety of the human embryo, on the other hand, had led to the establishment of some precise indications for the execution of prenatal diagnosis: the mother was not to be more than 35-38 years old.
In the eugenic perspective which is prevailing in society, also supported by legislative measures, this criterion is considered insufficient because too many "undesired" subjects, affected by serious malformations, would still be part of it. Studies were therefore carried out in order to find other parameters with would reveal an increased risk of chromosomic pathology for the embryo or fetus quite early during the pregnancy, like the alfa-feto-protein test and triple test.
From the ethical point of view, although the research of a correct and efficient method to predict the risk for a fetus to be affected by a chromosomal syndrome is good, its application is good and licit when , and only when, the aim of the application is good, that is any eugenic perspective is absent, no harm can derive to the women, to the child and to society.
From the deontological point of view, given the conditions for a licit applications, it must be underlined mainly the obligation of informed consent to predictive test, that is, complete and accurate information and serious quality control, in other words a precise verification of the gestational age of the fetus and a correct definition of risk.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
An Open Access Publication is one that meets the following two conditions:
- the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.